Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Theracryf PLC Company Timeline (TCF)
Dr Huw Jones, CEO of TheraCryf plc, on Positive Ox-1 Toxicology Data, Commercial Partner Interest and the Path to Human Trials
TCF Share
Price
TCF Share
News
TCF Share
Chat3
TCF Share
Trades37
TCF
Live RNS
TCF Share
Charts
TCF Level 2
Console
TCF Live
Share Price
TCF Broker
Ratings
TCF Directors
Deals
TCF Financial
Diary
TCF
Fundamentals
TCF Short
Positions
TCF
Media1
TCF Company
Research
TCF Company
Timeline1
Share Price Information for Theracryf PLC (TCF)
Last checked at -
Last checked at 
Intraday Theracryf PLC Share Chart
Latest Timeline Updates for Theracryf PLC
TCF
RNSTCF
MediaDr Huw Jones, CEO of TheraCryf plc, on Positive Ox-1 Toxicology Data, Commercial Partner Interest and the Path to Human Trials
TheraCryf plc ( TCF ) is a biotechnology company developing novel treatments for addiction and other neuropsychiatric disorders. Its lead Ox-1 blocker programme is advancing toward first-in-human s...
TCF
RNSTCF
NewsEARNINGS & TRADING: Nexus Infrastructure first-half loss narrows
The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
TCF
NewsTheracryf upbeat on initial toxicology data from lead programme
(Sharecast News) - Theracryf said on Thursday that initial toxicology data from its lead Ox-1 blocker addiction programme showed the drug was well tolerated at very high doses, as clinical trial-enabl...
TCF
NewsLONDON MARKET MIDDAY: Shares up as Strait of Hormuz talks lift mood
(Alliance News) - Stock prices in London were higher by midday Thursday, with the FTSE 100 building on early gains as investors digested developments in US-China talks and awaited a heavy slate of US...
TCF
NewsWINNERS & LOSERS: Auction upgrades guidance; Aquila talks break down
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday.
TCF
RNSTCF
RNSTCF
NewsTRADING UPDATES: Catenai renews contract; Angus sees production uplift
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
TCF
NewsTheraCryf manufactures over 2kg of Ox-1 receptor antagonist substance
(Sharecast News) - TheraCryf said on Monday that it has successfully manufactured clinical-grade material for its lead Ox-1 receptor antagonist, marking a key step towards initiating human trials.
Follow the stocks
